Novodiag® CarbaR+ Assay
High-performing, fully-automated on-demand screening of the most clinically relevant carbapenemases and colistin resistance in one single test.
Overview
Documents
Assay Highlights
The Novodiag® CarbaR+ assay, performed with the Novodiag System, is a cartridge-based molecular test for qualitative detection of carbapenemases and colistin resistance. The test uses rectal swabs and pure cultures from patients.
CE marked. Not for sale in the US.
Smart simplicity in on-demand testing
Cartridge-based, on-demand testing, that delivers clinical confidence in approximately an hour.
Features & Benefits
The Novodiag® assays allow a simple and fast way to pinpoint patients most at risk with targeted, multiplex and syndromic on-demand testing.
- Improved patient safety
- Fast infection control implementation and epidemiological surveillance
- Faster diagnosis compared to traditional methods
- Time and cost effectiveness
- Improved patient outcome
- Improved workflow and time to results
- Increased lab revenue
- Better reproducibility, precision and productivity
- Time and labour saving
- No need for highly trained personnel enabling decentralised testing
Documents
The Novodiag CarbaR+ enables on-demand screening of the most clinically relevant carbapenemases and colistin resistance in one single test.
